Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways
出版年份 2017 全文链接
标题
Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 3, Pages 2502-2512
出版商
Wiley
发表日期
2017-08-04
DOI
10.1002/jcp.26126
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways
- (2015) Ming-Ming Ma et al. INFLAMMATION
- Protein Kinase C Inhibitor, GF109203X Attenuates Osteoclastogenesis, Bone Resorption and RANKL-Induced NF-κB and NFAT Activity
- (2015) Jun Yao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Relationship Between Oxidative Stress and Bone Mass in Obesity and Effects of Berry Supplementation on Bone Remodeling in Obese Male Mice: An Exploratory Study
- (2015) Sang Gil Lee et al. JOURNAL OF MEDICINAL FOOD
- Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model
- (2015) Jianbin Huang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
- (2014) Zanjing Zhai et al. BREAST CANCER RESEARCH AND TREATMENT
- Choline Kinase β Mutant Mice Exhibit Reduced Phosphocholine, Elevated Osteoclast Activity, and Low Bone Mass
- (2014) Jasreen Kular et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Delphinidin, One of the Major Anthocyanidins, Prevents Bone Loss through the Inhibition of Excessive Osteoclastogenesis in Osteoporosis Model Mice
- (2014) Sawako Moriwaki et al. PLoS One
- SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation
- (2013) Qian Liu et al. BIOCHEMICAL PHARMACOLOGY
- Andrographolide suppresses RANKL-induced osteoclastogenesisin vitroand prevents inflammatory bone lossin vivo
- (2013) Z J Zhai et al. BRITISH JOURNAL OF PHARMACOLOGY
- Public Health Impact of Osteoporosis
- (2013) J. A. Cauley JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Loss of Protein Kinase C-δ Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone Resorption
- (2013) Ee Cheng Khor et al. PLoS One
- Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation
- (2011) Estabelle S.M. Ang et al. FEBS LETTERS
- Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo
- (2010) Kihyun Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK
- (2010) Estabelle Ang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis
- (2009) HaoTian Feng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anthocyanin attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation
- (2008) Min Xia et al. ATHEROSCLEROSIS
- NF-κB modulators in osteolytic bone diseases
- (2008) Jiake Xu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- PU.1 and NFATc1 mediate osteoclastic induction of the mouse β3 integrin promoter
- (2008) Tania N. Crotti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Receptor Activator of Nuclear Factor-κB Ligand-Induced Nuclear Factor of Activated T Cells (C1) Autoregulates Its Own Expression in Osteoclasts and Mediates the Up-Regulation of Tartrate-Resistant Acid Phosphatase
- (2007) Jackie A. Fretz et al. MOLECULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started